By Amit Srivastava
Humans are made of ingredients casually called nutrition or food. These ingredients not only drive the 7000 reactions leading to multiple outputs in our body, but also support 300 trillion probiotics living in our gut. Giving a nutraceutical supplement with the reductionist (molecule) approach of pharma for an indication in a metabolic disease patient will not yield any reasonable outcome.
This calls for an understanding of systemic metabolic conditions and the medicine being given at that period of time. It’s important to understand how the metabolic conditions change with disease progression and change of medicines.
Could we put the patient on a specific nutrition cocktail that eases the condition leading to maintaining low doses of medicines?
Welcome to responsible nutrition. Healthcare companies offering nutrition have a serious responsibility. A simple whey protein for a type 2 diabetes patient could trigger faster progression of diabetes because of its quantity of methionine or beta casein; that same whey protein could be the fuel to aggressively growing cancer cells due to it being a rich source of glutamine and aromatic acids. This well-balanced nutrition could be more dangerous to the patient than expected.
This is just an illustration of responsible nutrition. For healthcare companies, nutrition and nutraceuticals should be given as a purpose—better health outcomes for a specific metabolic disease while tackling the medical condition with pharmaceuticals. This would also call for changing the nutrition cocktail for the different stages of metabolic disease.
This calls for studying nutrition more as a science and not as an enhanced food support for some indication. This also means building therapy and metabolic stage driven nutrition cocktail tools for effective disease journey management. These tools give the body an opportunity to revive and combat the health condition while the direct treatment with pharmaceuticals continues.